NASHVILLE, Tenn.--(BUSINESS WIRE)-- Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Applications (NDAs) ...
Tobradex ST contains tobramycin, an antibacterial drug, and dexamethasone, a potent corticosteroid. Eyevance announced the launch of Tobradex® ST (tobramycin ...
Please provide your email address to receive an email when new articles are posted on . Eye care pharmaceutical company Harrow announced the completed transfer of new drug applications for Flarex, ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the ...
ALLEGAN, Mich., March 21, 2022 /PRNewswire/ -- Padagis today announced the FDA approval and launch of an AB-rated generic version of Tobradex® Ophthalmic Suspension. Tobradex® Ophthalmic Suspension is ...
FORT WORTH, Texas, March 2, 2020 /PRNewswire/ -- Eyevance Pharmaceuticals, committed to developing and commercializing innovative and impactful ophthalmic products ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved an abbreviated new drug application for Alembic Pharmaceuticals’ tobramycin ophthalmic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results